GUTS Q2 2025 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$26M

Net Income

-$28M

EPS (Diluted)

$-0.57

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$62M

Total Liabilities

$80M

Stockholders' Equity

-$18M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$43,000	-100.0%
Gross Profit	$0	$19,000	-100.0%
Operating Income	-$26M	-$23M	-13.5%
Net Income	-$28M	-$17M	-61.9%